Get started
Live feed
·
SECFilingvia Quantisnow
Pasithea Therapeutics Corp. logo

KTTA: SEC Form 25-NSE filed by Pasithea Therapeutics Corp.

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for KTTA

Across the 19 sessions after earlier KTTA headlines, the stock closed higher 6 times and lower 13 times, with a median move of 3.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

KTTA close-to-close change in the session after earlier headlines
SessionEarlier headlineKTTASPY
Sep 14, 2026Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference-3.8%-0.4%
Sep 4, 2026Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences-0.1%-0.4%
Jul 21, 2026Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026-3.9%+0.8%
Jul 8, 2026Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit-1.6%-0.3%
Jun 30, 2026Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion-2.0%+0.8%
Jun 16, 2026Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial-8.9%-0.6%
Quantisnow market dataNASDAQ
Pasithea Therapeutics Corp. logo
KTTA
Pasithea Therapeutics Corp.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for KTTA

Follow KTTA and get a push notification the moment its next story breaks.

Full KTTA profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KTTA (Pasithea Therapeutics Corp.) and more on Quantisnow.